InvestorWire NewsRoom

InvestorNewsBreaks

NewsBreak Category: Hemp
Friday Sep 20, 2024 - 3:30 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating ‘More Effective, Tolerable’ Oral Delivery of GLP-1 Drugs

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, looks to offer a better alternative to diabetes management and treatment through its patented DehydraTECH(TM) technology. “Lexaria has recently made strides with glucagon-like peptide-1 (‘GLP-1’) studies. It has reported positive interim results from an animal study on diabetes. This milestone best showcases the potential of its patented technology in not only addressing diabetes…

Continue Reading

Friday Sep 13, 2024 - 3:27 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing Market Potential with Unique Delivery Platform, GLP-1 Program

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently released its fiscal report for the third quarter of the 2024 financial year (“Q3, 2024”). “Of note was growth in cash and marketable securities from $1.5 million during the same period in the 2023 financial year to $8.5 million as of May 31, 2024. The company reduced certain R&D expenditures and experienced other savings,” reads a recent article. “Most…

Continue Reading

Friday Aug 30, 2024 - 2:45 pm

InvestorNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) BayMedica Poised as Rare Cannabinoids Drive Market Growth

InMed Pharmaceuticals’ (NASDAQ: INM) subsidiary BayMedica is positioned amid a growing interest in edibles infused with non-intoxicating minor cannabinoids. These lesser-known cannabinoids offer unique properties and potential health benefits, driving significant market growth. The company published a report on the expansion of the minor cannabinoid market in 2023. “The report, based on data from Headset, the largest industry dataset, explores the growth, competition and consumer…

Continue Reading

Friday Aug 30, 2024 - 1:15 pm

InvestorNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Makes ‘Transformative Step’ in Vision to Build Diverse Portfolio

Golden Triangle Ventures (OTC: GTVH) previously announced a full-service freight brokerage business designed to significantly expand its logistics capabilities in a strategic move that aligns with its vision to assemble a strong portfolio. “The announcement comes as the company completed its acquisition of Cargo Management Group from T&K Zarro LLC and received the full financial commitment needed to launch the freight brokerage business. The Cargo…

Continue Reading

Friday Aug 30, 2024 - 9:39 am

InvestorNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) Releases Q2 2024 Financial Report, Business Update

Red White & Bloom (CSE: RWB), a multistate cannabis operator and house of premium brands, is reporting the results of its second quarter 2024, the period ended June 30, 2024. Highlights of the report included advancing refinancing agreements with strategic lenders, progress made toward opening five new retail locations in Florida, stronger vendor relationships and the establishment of key distribution partnerships in California designed to…

Continue Reading

Monday Aug 19, 2024 - 10:05 am

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports on Positive Results from Molecular Characterization Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has released a report noting the positive findings from its applied research program. The program, which evaluated important mode of action facets of DehydraTECH(TM) processed with semaglutide, the glucagon-peptide 1 (“GLP-1”) drug, was conducted with the National Research Council of Canada ("NRC"). According to the company, the program was designed to examine the molecular…

Continue Reading

Friday Aug 16, 2024 - 3:03 pm

InvestorNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089 Showing Great Promise in Treating AMD

InMed Pharmaceuticals (NASDAQ: INM), a clinical stage company developing a pipeline of pharmaceutical drug candidates to treat several diseases with a high unmet medical need, is at the forefront of developing innovative treatment for age-related macular degeneration (“AMD”), with its flagship product INM-089 showing great promise. “AMD is a prevalent eye condition that primarily affects older adults, leading to vision loss in the central part…

Continue Reading

Friday Aug 16, 2024 - 2:30 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing Opportunity from First-Ever Work with Tirzepatide Molecule

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently hired a Contract Research Organization (“CRO”) for its third human pilot study. “This marks a milestone for the company, notably since it announced its focus solely on glucagon-like peptide 1 (‘GLP-1’) studies for the 2024 calendar year… This randomized, crossover investigation will evaluate a dual-action GLP-1 + glucose-dependent insulintropic peptide (‘GIP’), specifically…

Continue Reading

Thursday Aug 15, 2024 - 9:58 am

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Reports on Voting Results of 2024 Annual and Special Meeting of Shareholders

Flora Growth (NASDAQ: FLGC), a consumer-packaged goods leader and pharmaceutical distributor, is reporting on its 2024 Annual and Special Meeting of Shareholders. The meeting. According to the announcement, shareholders voted on and approved all five proposals on the agenda. Proposals included the election of four directors to the company’s board of directors; the reappointment of Davidson & Company LLP, an independent registered public accounting firm,…

Continue Reading

Wednesday Aug 14, 2024 - 2:30 pm

InvestorNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Eyes Expansion into More Lucrative Markets

Golden Triangle Ventures (OTC: GTVH) recently completed the acquisition of Cargo Management Group, a multifaceted logistics and trucking operation. “A complete shipping, logistics and trucking operation, Cargo Management Group will be a key component in providing support for GTVH’s Lavish Entertainment division. With the acquisition completed, Golden Triangle is now focused on facilitating the company’s assumption of full ownership of the logistics operation, brokerage business,…

Continue Reading

Friday Aug 09, 2024 - 9:48 am

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) CEO Comments on ‘Incredible Journey’ of CBD in Statement Celebrating National CBD Day

Flora Growth (NASDAQ: FLGC), a consumer-packaged goods leader and pharmaceutical distributor, is “proudly” celebrating National CBD Day. In a statement recognizing the day, which is dedicated to recognizing the benefits and rapid growth of the CBD industry in the United States and beyond, the company noted that “National CBD Day not only celebrates the therapeutic benefits of cannabidiol (‘CBD’) but also serves as a reminder…

Continue Reading

Thursday Aug 08, 2024 - 9:38 am

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Now Trading on Frankfurt Stock Exchange  

Flora Growth (NASDAQ: FLGC), a consumer-packaged goods leader and pharmaceutical distributor, through its JustCBD brand, is now trading its common shares on the Frankfurt Stock Exchange ("FSE") under the symbol 7301. According to the announcement, the FSE is the world’s third largest stock organized exchange-trading market, behind U.S.-based NASDAQ and the New York Stock Exchange (“NYSE”), based on terms of turnover and dealings with securities.…

Continue Reading

Tuesday Aug 06, 2024 - 1:24 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases “Noteworthy” Weight-Loss Results from Recent Animal Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is reporting recent results from its WEIGHT-A24-1 animal study. A recent article notes that interim results, which are based on the first 28 days of dosing, are “noteworthy,” including all animals showing either a noticeable decrease in the rate of body weight gain or the beginning of weight reduction. According to the article, the…

Continue Reading

Thursday Jul 11, 2024 - 2:00 pm

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Significant Improvements from INM-089 in AMD, Validates INM-901 as Potential AD Treatment

InMed (NASDAQ: INM) is a clinical stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors. The company recently released several critical updates regarding its INM-089 therapy treating dry Age-related Macular Degeneration (“AMD”) and its INM-901 small molecule drug candidate targeting Alzheimer’s disease (“AD”). “Recent preclinical data for INM-089 demonstrated significant functional and pathological improvements in an…

Continue Reading

Thursday Jul 11, 2024 - 10:13 am

InvestorNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Hails ABI Create’s ‘Stellar Reputation and Proven Track Record’ Amid Plans to Make Destino Ranch a World-Class Destination

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, today provided an update on ABI Create’s legacy and vision for the future. ABI Create is a division within Lavish Entertainment, a wholly owned subsidiary of Golden Triangle Ventures. Founded in 2015 by Marco Antonio Moreno, ABI Create has earned a reputation for delivering top-quality productions at major events across the United States. ABI Create offers…

Continue Reading

Wednesday Jul 10, 2024 - 12:30 pm

InvestorNewsBreaks – Astrotech Corporation (NASDAQ: ASTC) Sets New Standard for Accuracy, Reliability in Narcotics Detection

Astrotech (NASDAQ: ASTC), through its subsidiary 1st Detect, is revolutionizing narcotics and explosives trace detection. “With recent approval as a U.S. General Services Administration (‘GSA’) authorized vendor, 1st Detect is poised to expand its impact across government agencies. TRACER 1000 is a cutting-edge detector utilizing ruggedized mass spectrometry technology for superior detection at critical security points. 1st Detect’s commitment to excellence is underscored by its…

Continue Reading

Tuesday Jul 09, 2024 - 2:45 pm

InvestorNewsBreaks – CannaCon Event to Propel Networking, Knowledge Exchange in Fast-Growing Sector

CannaCon, a premier conference company that produces state-of-the-art B2B events for cannabis businesses, marijuana entrepreneurs, investors, and community partners to showcase industry products, people, innovations, and technology, today announced plans to host the 5th CannaCon Midwest St.Paul on Aug. 16-17, 2024. The event, designed to drive growth of the cannabis industry in both the Midwest and nationally while creating lasting value for the sector through…

Continue Reading

Monday Jul 08, 2024 - 2:26 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Secures New Patents for Antiviral Drug Delivery, Treating Epilepsy

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced three new patent awards. In the European Union, the company received a new patent in Lexaria’s patent family #6: Transdermal and/or Dermal Delivery of Lipophilic Active Agents. Following an earlier one granted in Canada, this is the company’s second patent in this family. In Canada, Lexaria has received a new patent…

Continue Reading

Monday Jul 01, 2024 - 2:00 pm

InvestorNewsBreaks – Golden Triangle Ventures Inc.’s (GTVH) Lavish Moves to Become Staple in the Entertainment Industry

Golden Triangle Ventures’ (OTC: GTVH) Lavish Entertainment embodies GTVH’s focus on vertical integration to cut costs and maximize margins, as evidenced by its recently released four-pillar business model. “According to GTVH, this strategic framework provides an essential piece of Lavish’s mission to create an industry leading entertainment business. The company’s new model includes key foundational elements – logistics, staffing, equipment and production – that were…

Continue Reading

Thursday Jun 27, 2024 - 3:30 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing Favorable Strategic Partnering with Leading GLP-1 Players

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is doubling down on glucagon-like peptide 1 (“GLP-1”) studies for the 2024 calendar year. “The company is optimistic that the studies will yield positive results, not just in the potential treatment of diabetes but also in weight management, which has been directly linked to diabetes… The company recently received independent third-party ethics review…

Continue Reading

Thursday Jun 20, 2024 - 12:09 pm

InvestorNewsBreaks – Astrotech Corporation’s (NASDAQ: ASTC) TRACER 1000(TM) Receives ‘Approved’ Status on Air Cargo Security Technology List

Astrotech (NASDAQ: ASTC) and its wholly owned subsidiary, 1st Detect Corporation, today announced that the U.S. Transportation Security Administration (“TSA”) has approved the TRACER 1000(TM) for the Air Cargo Security Technology List (“ACSTL”) following thorough assessment by the TSA QG2 Technical Review Panel (“TRP”). Following the approval, regulated parties in the U.S., such as the air cargo market, which are required to use the ACSTL,…

Continue Reading

Tuesday Jun 18, 2024 - 12:48 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Engages CRO for DehydraTECH GLP-1 Human Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced it has hired a contract research organization (“CRO”) to oversee execution of the company’s 12-week chronic study GLP-1-H24-4. The study will evaluate various DehydraTECH-GLP-1 (glucagon-like peptide) formulations and other treatments with efficacy objectives of weight loss, blood sugar reduction and more. “This study will be the most comprehensive and impactful GLP-1…

Continue Reading

Friday Jun 14, 2024 - 10:31 am

InvestorNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Receives Full Financial Commitment to Move Forward with Launch of Freight Brokerage Division

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, has received the financial commitment required to launch an internal, full-service freight-brokerage business designed to significantly expand its logistics capabilities. GTVH made this announcement following the completed acquisition of Cargo Management Group from TK Zarro LLC; the acquisition includes a logistics operation, brokerage business, licenses and all associated assets. The announcement noted that the company received…

Continue Reading

Thursday Jun 13, 2024 - 1:13 pm

InvestorNewsBreaks – Astrotech Corp. (NASDAQ: ASTC) Subsidiary Partners with Multistate Testing Lab to Market Proprietary AgLAB Solutions

Astrotech (NASDAQ: ASTC), an innovative science and technology company, and its subsidiary, AgLAB, have entered into a master lease agreement with SC Labs; the companies are working together to jointly market the AgLAB 1000-D2(TM) mass spectrometer and the AgLAB Maximum Value Process testing method to SC Labs customers. AgLAB has pioneered applications featuring the Astrotech Mass Spectrometer Technology that specifically target the hemp and cannabis markets while SC…

Continue Reading

Thursday Jun 06, 2024 - 9:20 am

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Acquisition of Australian Vaporizers

Flora Growth (NASDAQ: FLGC), a consumer-packaged goods leader and pharmaceutical distributor, has entered into and closed on a share purchase agreement; the agreement is to acquire all issued and outstanding shares of Australian Vaporizers Pty Limited in exchange for 550,000 Flora common shares. According to the announcement, the Flora shares are valued at $0.7 million based on the closing price of the company’s common shares…

Continue Reading

Wednesday Jun 05, 2024 - 10:48 am

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Acquires Aussie Vapes

Lifeist Wellness Inc. (TSX.V: LFST) (OTC: LFSWF) (FRA: M5B), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, today announced the sale of Australian Vaporizers Pty Ltd. (“Aussie Vapes”), its wholly owned Australian subsidiary, to Flora (NASDAQ: FLGC), a U.S.-based consumer-packaged goods and pharmaceutical distributor serving all 50 states and 28 countries. The sale was completed…

Continue Reading

Friday May 31, 2024 - 10:24 am

InvestorNewsBreaks – CWCBExpo Set to Begin 10th Annual Event, Offer ‘Essential Resources and Information for Success’

Cannabis World Congress & Business Exposition (“CWCBExpo”), the leading East Coast cannabis conference and trade show, is set to begin next week in New York City. The event, which is scheduled for June 5–6, features an immersive exhibition space, leading speakers and presenters, and invaluable business-building opportunities and after parties. This year CWCBExpo partnered with the New York Cannabis Workforce Initiative to showcase workforce development, legal…

Continue Reading

Friday May 31, 2024 - 9:21 am

InvestorNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) Releases Q1 2024 Financial Report, Business Update

Red White & Bloom (CSE: RWB), a multistate cannabis operator and house of premium brands, has filed its Condensed Interim Consolidated Financial Statements, Management's Discussion and Analysis, and other associated certifications for first quarter 2024, the period ended March 31, 2024. In addition, the company noted that it will be holding its Annual General Meeting on on June 14, 2024. Business highlights from the report…

Continue Reading

Thursday May 30, 2024 - 12:20 pm

InvestorNewsBreaks – Flora Growth Corp.’s (NASDAQ: FLGC) Vessel Brand Releases Standout Second-Generation Compass Rise

Flora (NASDAQ: FLGC) is a cannabis-focused consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world. Flora’s Vessel Brand, renowned for its design and precision craftsmanship, announced today the release of Compass Rise. Compass Rise has a sleek design, cutting-edge technology, and the ability to stay upright, with every aspect of the product reflecting…

Continue Reading

Tuesday May 28, 2024 - 9:52 am

InvestorNewsBreaks – Golden Triangle Ventures Inc. (GTVH), T&K Zarro Ink Agreement to Strengthen Capital Structure, Drive Shareholder Value

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, has entered a pivotal agreement with T&K Zarro LLC. Golden Triangle called the agreement a “significant step towards solidifying GTVH's capital structure, expanding its business operations and enhancing shareholder value.” Managed by Tom Zarro, T&K Zarro is the largest note holder in GTVH. The agreement outlines T&K Zarro’s commitment to a “structured and disciplined sale of…

Continue Reading

Friday May 24, 2024 - 1:36 pm

InvestorNewsBreaks – CWCBExpo, the World’s Most Sought-After Business Trade Show Event in Legalized Cannabis Space, Returns to New York City

The 10th Annual CWCBExpo (Cannabis World Congress & Business Exposition), the premier East Coast business-to-business trade show and sector-shaping event for the hemp and cannabis industry, is returning to New York City. The expo will be held on June 5-6, 2024, at the iconic Javits Convention Center. The two-day CWCBExpo promises to deliver world-class educational sessions led by industry veterans and thought leaders, with nearly…

Continue Reading

Friday May 24, 2024 - 10:51 am

InvestorNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Executes LOI to Acquire Cargo Management Group

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, is announcing the execution of a Letter of Intent (“LOI”) with TK Zarro LLC, GTV’s primary note holder, to acquire Cargo Management Group. Golden Triangle Ventures is in the process of finalizing the acquisition. According to the announcement, Cargo Management is a complete shipping, logistics and trucking operation that achieved close to $3 million in top-line…

Continue Reading

Thursday May 23, 2024 - 10:47 am

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Selects CRO in Third GLP-1 Human Pilot Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is partnering with a contract research organization (“CRO”) to conduct its human pilot study #3. According to the announcement, this is the first-ever DehydraTECH(TM)-processed tirzepatide from Zepbound(R) to be tested in a swallowed oral format. The study is designed to evaluate a dual-action GLP-1 (glucagon-like peptide) plus GIP (glucose-dependent insulintropic peptide) in a randomized,…

Continue Reading

Tuesday May 21, 2024 - 2:53 pm

InvestorNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Moving to Build Complete Entertainment Enterprise

Golden Triangle Ventures (OTC: GTVH) and its entertainment division, Lavish Entertainment, are positioning for opportunity. “Most recently, the company took a significant step forward in the development of Destino Ranch into a premier music, art destination with the acquisition of ABI Create, an innovative event management and production company. Founded by Marco Antonio Moreno, who was recently named president and COO of Lavish Entertainment, ABI…

Continue Reading

Friday May 17, 2024 - 1:07 pm

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) CEO Notes White House, Presidential Support of Cannabis Rescheduling

Flora Growth (NASDAQ: FLGC), a consumer-packaged goods leader and pharmaceutical distributor, has released a statement regarding President Joe Biden and his administration’s actions regarding moving to reschedule cannabis under U.S. federal law. According to the announcement, President Biden has called rescheduling cannabis “monumental” and noted that it is an “important move towards reversing longstanding inequities.” The U.S. Department of Justice is expected to post its…

Continue Reading

Thursday May 16, 2024 - 3:10 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking to Tap into Various Growing Markets

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, has proven in numerous studies the ability of its patented DehydraTECH(TM) technology to increase bio-absorption compared to standard industry formulations, as well as reduce time of onset and deliver drugs more effectively across the blood-brain barrier. “DehydraTECH has a number of potential pharmaceutical applications, a testament to its versatility and overall effectiveness. The…

Continue Reading

Wednesday May 15, 2024 - 3:45 pm

InvestorNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Journeys Toward Creation of One-of-a-Kind Destination

Golden Triangle Ventures (OTC: GTVH) is a multifaceted consulting company that operates as a parent business pursuing ventures in the health, entertainment and technology sectors. GTVH and its entertainment division, Lavish Entertainment, are working with Cayenne Consulting on the strategic development of Destino Ranch. “Destino Ranch aims to redefine luxury entertainment and hospitality experiences. Set amid the breathtaking landscapes of the Mojave Desert, Destino Ranch…

Continue Reading

Tuesday May 14, 2024 - 12:23 pm

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q3 Fiscal 2024 Financial Results, Business Update

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates, is reporting on its financial and business results for the third quarter of 2024, the period that ended March 31, 2024. Business highlights included the announcement of preclinical data supporting both the company’s INM-901 and INM-089 programs; the continued development of its ALZ program, with long-term…

Continue Reading

Tuesday May 14, 2024 - 11:21 am

InvestorNewsBreaks — Zoned Properties Inc. (ZDPY) Releases Q1 2024 Financial Results Showing 22% Revenue Growth

Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company for emerging and highly regulated industries, including legalized cannabis, released its financial results for Q1 2024, the period ended March 31; the company also noted recent business highlights. According to the report, financial highlights include revenues totaling $837,052 for the quarter ended March 31, 2024, compared to $688,024 million revenues for the same quarter 2023, representing…

Continue Reading

Tuesday May 14, 2024 - 9:45 am

InvestorNewsBreaks – Astrotech Corp. (NASDAQ: ASTC) Releases Q3 202 Financial Report

Astrotech (NASDAQ: ASTC), an innovative science and technology company, is reporting its financial results for the third quarter of fiscal year 2024, for the period ended March 31, 2024. Highlights of the report include the company’s strong consolidated balance sheet showing $34.7 million in cash and liquid investments; revenue for the year-to-date coming in at $1.6 million; year-to-date gross margin increased to 45% from 37% through…

Continue Reading

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).